• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 15, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Protective T cells remain 20 months after COVID-19

Bioengineer by Bioengineer
July 21, 2022
in Health
Reading Time: 2 mins read
0
Th1 cells
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients infected with SARS-CoV-2 develop protective immune responses, mediated by virus-specific T cells and antibodies, shortly after the infection. There is concern, however, that immunity does not persist over time, which may translate into severe COVID-19 upon re-infection. 

Th1 cells

Credit: Martner et al/PNAS

Patients infected with SARS-CoV-2 develop protective immune responses, mediated by virus-specific T cells and antibodies, shortly after the infection. There is concern, however, that immunity does not persist over time, which may translate into severe COVID-19 upon re-infection. 

In the July, 12 issue of Proceedings of the National Academy of Sciences (PNAS), Anna Martner and co-authors at University of Gothenburg report two main findings. First, several variants of virus-specific T cells became detectable in blood shortly after COVID-19, but strikingly disappeared after 10-12 weeks.

However, a group of highly specialized T cells, designed to facilitate elimination of infected cells, remained active in the blood of all previously SARS-CoV-2-infected patients. These T cells did not disappear or wane even at long follow-up.

The findings may explain the reduced risk of severe disease and mortality among patients who have become re-infected with SARS-CoV-2.

Scientists at the University of Gothenburg and Sahlgrenska University Hospital collected 81 blood samples from hospital staff members who had contracted mild COVID-19 in the first year of the pandemic and uninfected controls. The researchers studied T cell reactivity to an inner part of SARS-CoV-2 (the virus nucleocapsid) thus capturing T cell responses that only occur after a natural infection.

The blood samples were exposed to more than 100 peptides from the nucleocapsid portion of SARS-CoV-2 virus. The researchers then analyzed which T cell mediators (cytokines) were produced by blood cells to determine the longevity of T cell reactivity after the infection.

It was observed that a subgroup of specialized T cells (Th1 cells) that promote destruction of virus-infected cells were active for at least 20 months after natural COVID-19. The infected patients also harbored several other types of T cells that reacted with SARS-CoV-2. These latter T cells disappeared from blood approximately 2 months after recovery from infection.

– While certain subsets of T cells disappear shortly after infection, highly specialized T cells (T helper 1 cells) remain stably present in blood to suggest that a vital aspect of protective immunity is functional years after COVID-19, says Anna Martner, Associate Professor of immunology at the Sahlgrenska Academy. These results may explain why re-infection with SARS-CoV-2 only rarely translates into severe COVID-19.



Journal

Proceedings of the National Academy of Sciences

DOI

10.1073/pnas.2203659119

Method of Research

Case study

Subject of Research

Human tissue samples

Article Title

Transient and durable T cell reactivity after COVID-19

Article Publication Date

12-Jul-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

AAV Variant Discovery Boosts Human Vascular Cell Transduction

November 15, 2025

Streamlined Inversion of Genomic DNA at Chromosomal Scale

November 15, 2025

Holistic Approaches for Testicular Cancer Recovery: Exercise, Diet, Support

November 15, 2025

Unveiling the Structure and Function of Nuclear Pores

November 15, 2025

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    318 shares
    Share 127 Tweet 80
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    210 shares
    Share 84 Tweet 53
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    201 shares
    Share 80 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    142 shares
    Share 57 Tweet 36

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AAV Variant Discovery Boosts Human Vascular Cell Transduction

Optimizing Co-Mn Oxide Coatings for SOC Interconnects

Streamlined Inversion of Genomic DNA at Chromosomal Scale

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.